Tower Research Capital (TRC)’s CF Acquisition Corp. IV Class A common stock CFIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-229
Closed -$2.44K 6308
2023
Q3
$2.44K Buy
229
+94
+70% +$993 ﹤0.01% 5151
2023
Q2
$1.42K Buy
+135
New +$1.41K ﹤0.01% 5380
2022
Q2
Sell
-472
Closed -$4K 6741
2022
Q1
$4K Sell
472
-184
-28% -$1.8K ﹤0.01% 5293
2021
Q4
$6K Buy
656
+231
+54% +$2.26K ﹤0.01% 5092
2021
Q3
$4K Sell
425
-400
-48% -$3.88K ﹤0.01% 5024
2021
Q2
$8K Buy
825
+426
+107% +$4.16K ﹤0.01% 4523
2021
Q1
$4K Buy
+399
New +$3.99K ﹤0.01% 4830

Tower Research Capital (TRC)'s CFIV Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of CF Acquisition Corp. IV Class A common stock (CFIV) in Q4 2023, closing a stake of 229 shares — an estimated $2.44K sold.

Tower Research Capital (TRC) first reported a position in CFIV in Q1 2021 and held it in 7 quarters. The position peaked at $8K in Q2 2021. 0 funds tracked by Wall St. Rank hold CFIV as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining CF Acquisition Corp. IV Class A common stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 229 CF Acquisition Corp. IV Class A common stock shares in Q4 2023, an estimated $2.44K.
  • Tower Research Capital (TRC) first reported a position in CF Acquisition Corp. IV Class A common stock in Q1 2021 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s CF Acquisition Corp. IV Class A common stock position peaked at $8K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CF Acquisition Corp. IV Class A common stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.